| 0 (0%) | 04-25 14:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.4  |
1-year : | 1.51 |
| Resists | First : | 1.2 |
Second : | 1.29 |
| Pivot price | 1.14 |
|||
| Supports | First : | 1.03 |
Second : | 0.86 |
| MAs | MA(5) : | 1.07 |
MA(20) : | 1.17 |
| MA(100) : | 1.29 |
MA(250) : | 1.51 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 5.5 |
D(3) : | 7.1 |
| RSI | RSI(14): 20.6 |
|||
| 52-week | High : | 2.74 | Low : | 1.03 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ENZ ] has closed above bottom band by 8.9%. Bollinger Bands are 49.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.12 |
| Low: | 1.03 - 1.04 | 1.04 - 1.05 |
| Close: | 1.05 - 1.06 | 1.06 - 1.07 |
Mon, 22 Apr 2024
Cardiac enzymes: Test for heart attacks and more - Medical News Today
Wed, 03 Apr 2024
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing - PR Newswire
Wed, 28 Feb 2024
New role for bacterial enzyme in gut metabolism revealed - Penn State University
Fri, 16 Feb 2024
Humans Rely on Gut Bacteria for an Enzyme that Prevents Jaundice - The Scientist
Thu, 15 Feb 2024
Do digestive enzyme supplements really work? Experts weigh in - CNN
Wed, 31 Jan 2024
Researchers find enzyme plays much larger role in preventing neurodegenerative diseases - IU Newsroom
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 51 (M) |
| Shares Float | 39 (M) |
| Held by Insiders | 24.1 (%) |
| Held by Institutions | 39.5 (%) |
| Shares Short | 721 (K) |
| Shares Short P.Month | 715 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.39 |
| Profit Margin | 99.2 % |
| Operating Margin | -25.6 % |
| Return on Assets (ttm) | -16.6 % |
| Return on Equity (ttm) | -45.1 % |
| Qtrly Rev. Growth | 13.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.64 |
| EBITDA (p.s.) | -0.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -44 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -2.24 |
| PEG Ratio | 0 |
| Price to Book value | 0.75 |
| Price to Sales | 1.63 |
| Price to Cash Flow | -1.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|